LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL)

Clinical trials for LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL) explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL) trials appear

Sign up with your email to follow new studies for LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New Two-Drug attack on tough blood cancers begins human testing

Disease control Recruiting now

This is an early-stage study testing the safety and initial effectiveness of a new drug combination called UB-VV111 plus rapamycin. It is for adults with certain advanced B-cell blood cancers (like lymphoma and leukemia) that have come back or stopped responding to other treatmen…

Matched conditions: LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL)

Phase: PHASE1 • Sponsor: Umoja Biopharma • Aim: Disease control

Last updated Apr 01, 2026 21:41 UTC

LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL)

Get alerted when new LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL) trials appear

New Two-Drug attack on tough blood cancers begins human testing